“…7 Recent studies have shown that there is an increased prevalence of the C282Y mutation in patients with porphyria cutanea tarda, a disorder of heme metabolism associated with hepatic hemosiderosis. 8,9 Heterozygosity for hemochromatosis has also been considered to be a risk factor in previous studies of patients with hepatitis C, 3,7,[10][11][12] alcoholic liver disease, 3,7 nonalcoholic steatohepatitis, 13 and ␣ 1 -antitrypsin deficiency. 14 Also, in some hemochromatosis pedigrees, C282Y heterozygotes or compound heterozygotes may, albeit uncommonly, have hemosiderosis in the range of C282Y homozygotes.…”